AILERON THERAPEUTICS INC (ALRN)

US00887A2042 - Common Stock

4.16  -0.39 (-8.57%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
15.35M27.65M26.61M20.50M29.96M
Research and Development
3.99M17.97M17.01M11.17M17.66M
Selling, General, and Administrative Expenses
11.36M9.68M9.60M9.33M12.29M
Operating Income
-15.35M-27.65M-26.61M-20.50M-29.96M
Interest Income/Expense
400.00K300.00KN/AN/A590.00K
Other Income/Expense
144.00K20.00K40.00K40.00KN/A
Non Recurring Items
-928.00KN/A300.00KN/AN/A
Income Before Taxes
-15.73M-27.33M-26.16M-21.16M-29.37M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-15.73M-27.33M-26.16M-21.16M-29.37M
EBITDA
-15.23M-27.48M-26.49M-20.34M-29.80M
 
Per Share Data
EPS Diluted Total Ops
-3.42-6.02-5.89-12.16-23.87
Non GAAP EPS
N/A-6.02-5.80-12.60-25.80
 
Statistics

All data in USD

Charts